We are live on ! Find out more
BAMS

Bellevue Asset Management (Switzerland) Portfolio holdings

AUM $656M
1-Year Est. Return 11.45%
This Fund
S&P 500
This Quarter Est. Return
+12.15%
1 Year Est. Return
+11.45%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$717M
AUM Growth
–
Cap. Flow
+$692M
Cap. Flow %
96.53%
Top 10 Hldgs %
28.85%
Holding
141
New
141
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$27.9M
2
CELG
Celgene Corp
CELG
+$27M
3
MDT icon
Medtronic
MDT
+$25.8M
4
GILD icon
Gilead Sciences
GILD
+$23.7M
5
ABT icon
Abbott
ABT
+$23.3M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 85.25%
2 Financials 0.88%
3 Industrials 0.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNP
126
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$682K 0.1%
+110,000
New +$680K
ENTL
127
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$657K 0.09%
+30,000
New +$648K
TNDM icon
128
Tandem Diabetes Care
TNDM
$1.62B
$631K 0.09%
+5,000
New +$650K
HNT
129
DELISTED
HEALTH NET INC
HNT
$605K 0.08%
+10,000
New +$563K
TSRO
130
DELISTED
TESARO, Inc.
TSRO
$591K 0.08%
+10,300
New +$485K
INVA icon
131
Innoviva
INVA
$1.5B
$550K 0.08%
+35,000
New +$530K
DYAX
132
DELISTED
DYAX CORPORATION
DYAX
$503K 0.07%
+30,000
New +$467K
TBPH icon
133
Theravance Biopharma
TBPH
$878M
$484K 0.07%
+27,891
New +$511K
MGNX icon
134
MacroGenics
MGNX
$257M
$471K 0.07%
+15,000
New +$508K
TTPH
135
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$440K 0.06%
+600
New +$451K
CERS icon
136
Cerus
CERS
$520M
$417K 0.06%
+100,000
New +$512K
PRXL
137
DELISTED
Parexel International Corp
PRXL
$345K 0.05%
+5,000
New +$319K
GERN icon
138
Geron
GERN
$1.01B
$170K 0.02%
+45,000
New +$153K
OEF icon
139
PUT
iShares S&P 100 ETF
OEF
$20.5B
$161K 0.02%
+100
New +$9.1K
AST
140
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$13K ﹤0.01%
+1,875
New +$9.29K
BTX.WS
141
DELISTED
BioTime Inc Warrants (Expiring October 1, 2018)
BTX.WS
$5K ﹤0.01%
+2,294
New +$3.08K
2 3 4 5
6

Similar funds

VFAM
Valley Forge Asset Management King Of Prussia, Pennsylvania $645M AUM 5.8% 1-Year Est. Return
MSU
Maple Securities USA Jersey City, New Jersey $672M AUM 1.03% 1-Year Est. Return
PSI
Pinnacle Summer Investments Fairfax, Virginia $678M AUM 9.5% 1-Year Est. Return
SFP
Santa Fe Partners Santa Fe, New Mexico $608M AUM 8.76% 1-Year Est. Return
MCM
Mazama Capital Management Portland, Oregon $544M AUM 9.52% 1-Year Est. Return
NMIS
Northwestern Mutual Investment Services Milwaukee, Wisconsin $525M AUM 2.45% 1-Year Est. Return
SM
Stratton Management King Of Prussia, Pennsylvania $824M AUM 1.57% 1-Year Est. Return
ZAM
Zenit Asset Management Stockholm, Sweden $450M AUM 8.32% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s Q1 2015 Portfolio in Review

Q1 2015 is the first quarter with a 13F filing on record for Bellevue Asset Management (Switzerland), which disclosed 141 positions worth $717M. Its ten largest holdings account for 29% of the portfolio.

Its largest position is Biogen: 70,730 shares worth $29.9M.

By sector, the portfolio is most concentrated in Healthcare at 85% of assets, followed by Financials and Industrials.

  • Bellevue Asset Management (Switzerland)'s largest Q1 2015 buy was Biogen: 70,730 shares worth $29.9M.
  • Bellevue Asset Management (Switzerland)'s ten largest holdings make up 29% of its $717M portfolio in Q1 2015.
  • Bellevue Asset Management (Switzerland) disclosed 141 positions in Q1 2015, its first 13F filing on record.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q1 2015, filed 14 May 2015.